In addition, 13 compounds targeting topoisomerase, CDK, and HDAC were selected to assess their response in 81 liver cancer cell line models in LIMORE, a pharmacogenomics database of liver cancer [28]. The gene discussed is HDAC9; the disease is liver cancer.